New Fissure-Attached Nodules in Lung Cancer Screening: A Brief Report From The NELSON Study.


Journal

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
ISSN: 1556-1380
Titre abrégé: J Thorac Oncol
Pays: United States
ID NLM: 101274235

Informations de publication

Date de publication:
01 2020
Historique:
received: 21 05 2019
revised: 03 09 2019
accepted: 06 09 2019
pubmed: 14 10 2019
medline: 7 1 2021
entrez: 14 10 2019
Statut: ppublish

Résumé

In incidence lung cancer screening rounds, new pulmonary nodules are regular findings. They have a higher lung cancer probability than baseline nodules. Previous studies have shown that baseline perifissural nodules (PFNs) represent benign lesions. Whether this is also the case for incident PFNs is unknown. This study evaluated newly detected nodules in the Dutch-Belgian randomized-controlled NELSON study with respect to incidence of fissure-attached nodules, their classification, and lung cancer probability. Within the NELSON trial, 7557 participants underwent baseline screening between April 2004 and December 2006. Participants with new nodules detected after baseline were included. Nodules were classified based on location and attachment. Fissure-attached nodules were re-evaluated to be classified as typical, atypical, or non-PFN by two radiologists without knowledge of participant lung cancer status. One thousand four hundred eighty-four new nodules were detected in 949 participants (77.4% male, median age 59 years [interquartile range: 55-63 years]) in the second, third, and final NELSON screening round. Based on 2-year follow-up or pathology, 1393 nodules (93.8%) were benign. In total, 97 (6.5%) were fissure-attached, including 10 malignant nodules. None of the new fissure-attached malignant nodules was classified as typical or atypical PFN. In the NELSON study, 6.5% of incident lung nodules were fissure-attached. None of the lung cancers that originated from a new fissure-attached nodule in the incidence lung cancer screening rounds was classified as a typical or atypical PFN. Our results suggest that also in the case of a new PFN, it is highly unlikely that these PFNs will be diagnosed as lung cancer.

Identifiants

pubmed: 31606605
pii: S1556-0864(19)33521-X
doi: 10.1016/j.jtho.2019.09.193
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

125-129

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Informations de copyright

Copyright © 2019 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

Auteurs

Daiwei Han (D)

Department of Radiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Marjolein A Heuvelmans (MA)

Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; Department of Pulmonology, Medisch Spectrum Twente, Enschede, Netherlands. Electronic address: m.a.heuvelmans@umcg.nl.

Carlijn M van der Aalst (CM)

Department of Public Health, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands.

Lisa H van Smoorenburg (LH)

Faculty of Medical Sciences, University of Groningen, Groningen, Netherlands.

Monique D Dorrius (MD)

Department of Radiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Mieneke Rook (M)

Department of Radiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; Department of Radiology, Martini Hospital, Groningen, Netherlands.

Kristiaan Nackaerts (K)

Department of Pulmonary Medicine, KU Leuven, University Hospitals Leuven, Leuven, Belgium.

Joan E Walter (JE)

Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Harry J M Groen (HJM)

Department of Pulmonology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Rozemarijn Vliegenthart (R)

Department of Radiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Harry J de Koning (HJ)

Department of Public Health, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands.

Matthijs Oudkerk (M)

Faculty of Medical Sciences, University of Groningen, Groningen, Netherlands; iDNA B.V., Groningen, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH